Maternal Immunization
Coordonnateurs : Leuridan Elke, Nunes Marta, Jones Chrissie
Immunization during pregnancy with currently recommended vaccines prevents infection in the mother, the unborn fetus, and the young infant, and there is an increasing focus from different stakeholders to use this approach for other infections of importance to protect these vulnerable groups. The aim of this Maternal Immunization book is to provide a contemporary overview of vaccines used in pregnancy (and the lactation period), with emphasis on aspects of importance for the target groups, namely, rationale for the use of vaccines in pregnancy, safety, immunogenicity (immunology), timing to vaccinate, repeat doses, protective effects in the mother, fetus, and infant, and public acceptance and implementation, of existing and of future vaccines.
Part I: Concepts of maternal immunization 1 The history of maternal immunization 2 Vaccination of women in the pre-conception and post-partum periods 3 Immunobiological aspects of vaccines in pregnancy: Maternal perspective 4 Immunobiological aspects of vaccines in pregnancy: Infant perspective 5 Global considerations on maternal vaccine introduction and implementation
Part II: Vaccines with current recommendations for use in pregnancy 6 Tetanus 7 Influenza 8 Pertussis 9 Vaccination in pregnancy in specific circumstances
Part III: Future vaccines for use in pregnancy 10 Respiratory syncytial virus 11 Group B Streptococcusc 12 Cytomegalovirus 13 Zika virus 14 Malaria
Part IV: Conclusion 15 Conclusion
Since 2015, she combines working in research with general practice.
Dr Marta Nunes is a Reader, Associate Professor, at the Vaccine Preventable Diseases Unit, Faculty of Health Sciences, University of the Witwatersrand, South Africa. Marta developed her PhD work at the Department of Neurology & Neuroscience, Weill Medical College of Cornell University, New York, USA and obtained her PhD from the University of Lisbon, Medical College, Portugal. After her post-doctoral training at the Institut Pasteur in Paris, France, where she developed different projects aimed at understanding the cell biology of Plasmodium falciparum and to identify molecular candidates for malaria vaccines for pregnant women, she moved to South Africa in 2009.
To approach the problem of infant morbidity and mortality related to infections she is exploring the potential of intervening through vaccination of pregnant women to protect the women and their babies against infections. This also includes the evaluation of this intervention in reducing adverse birth outcomes.
Dr Chrissie Jones is an Associate Professor in Paediatric In
- Provides an overview of a quickly evolving topic. This will benefit the reader who wishes to rapidly become informed and up-to-date with new developments in this field
- Suitable to a broad audience: scientific researchers, obstetricians, gynecologists, neonatologists, vaccinators, pediatricians, students, and industry. Maternal vaccination impacts a wide range of specialists
- Allows health care professionals/researchers to gain insight into other aspects of vaccination in pregnancy outside of their specialism
- Is coauthored by specialists from multiple disciplines, providing a diverse view of the subject, increasing its interest and appeal
- Creates awareness of the current developments in this area of medicine and of the potential of maternal vaccination to improve the health of mothers and infants worldwide
Date de parution : 11-2019
Ouvrage de 394 p.
15x22.8 cm
Thèmes de Maternal Immunization :
Mots-clés :
Antibodies; Blunting; Breast milk; Breastfeeding; Chondroitin sulfate A; Clostridium tetani; CMV vaccines; Congenital CMV infection; Congenital Zika syndrome; Correlate of protection; Cytomegalovirus; Diphtheria; Exposure; Fetus; Group B streptococcus; Haemophilus influenzae type B; Hepatitis B; Herpesviruses; Hib; History of vaccines; Immunity; Implementation; Infant; Infectious pathogens; Influenza; Influenza vaccines; Interference; Invasive disease; Malaria; Maternal; Maternal antibody; Maternal immunization; Maternal mortality; Maternal tetanus; Measles vaccine; Meningococcal; Microcephaly; Monoclonal antibody; Morbidity; Mortality; Neonatal mortality; Neonatal tetanus; Newborn; Operationalization; Outbreak; Pandemic; Pertussis; Pertussis vaccine; Pertussis vaccines; PfSPZ vaccine; Placenta; Plasmodium falciparum; Pneumococcal; Pregnancy; Pregnant women; Respiratory syncytial virus; RSV; Rubella; Sensorineural hearing loss; Sporozoites; Tdap vaccination; Tetanus; Tetanus toxoid; TORCH infections; Transmission blocking vaccine; Transplacental transfer; Travel; Vaccination; Vaccination in women; Vaccine; Vaccines; Vaccines pregnancy; VAR2CSA; Varicella; Viral envelope glycoproteins; Zika vaccine; ZIKV
